Urgent National Drug Shortage

Posted in Latest News on October 16, 2017.

The Department of Health was alerted that Fresenius Kabi has Xylocaine with epinephrine presentations on shortage due to increased demand for the product and manufacturing delays and Pfizer has lidocaine with epinephrine presentations on shortage due to manufacturing delays.

You can read more about these shortages at:

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=860 (for lidocaine with epinephrine)

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=937 (for bupivacaine with epinephrine



More Latest News

Important Information Regarding Rhopressa
June 26, 2018

Click here to find out more about Rule 64B13-18.002 formulary of Topical Ocular Pharmaceutical Agents, Rhopressa (netarsudil ophthalmic solution) 0.02%.) Continue reading


Third Quarterly Performance Report Released for the 2017-2018 Fiscal Year
June 8, 2018

The Quarterly Performance Report for the third quarter of the 2017-2018 fiscal year is now available online. Continue reading